Behavior of serum interleukin 12 in human acute pancreatitis

Pancreas

Volumn 18, Issue 3, 1999, Pages 247-251

  Pezzilli, Raffaele ^a   Miniero, Rita ^a   Cappelletti, Onda ^a   Barakat, Bahjat ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute pancreatitis; Interleukin 12; Interleukin 6

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 6;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOMODULATION; INFECTION; MALE; PANCREAS NECROSIS; PRIORITY JOURNAL;

EID: 0033055099     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199904000-00005     Document Type: Article

References (28)

1. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis: comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-7.
2. Gross V, Andreesen R, Leser HG, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22: 200-3.
3. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-8.
4. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101: 782-5.
5. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
6. Pezzilli R, Billi P, Miniero R, et al. Serum interleukin 6, interleukin 8, and β2 microglobulin in the early assessment of the severity of acute pancreatitis: a comparison with serum C-reactive protein. Dig Dis Sci 1995;40:2341-8.
7. Hamilton G, Hofbauer S, Hamilton B,. Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. Scand J Infect Dis 1992;24: 361-8.
8. Curley PJ, McMahon MJ, Lancaster F, et al. Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 1993;80:1312-5.
9. 2-macroglobulin. Dig Dis Sci 1990;35:97-105.
10. Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis. Gastroenterology 1996;110:639-42.
11. Pezzilli R, Billi P, Gullo L, et al. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion 1994;55:268-73.
12. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF). J Exp Med 1989; 170:827-36.
13. Stern AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-12.
14. Trinchieri G. Interleukin 12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-27.
15. Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G. Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 1995;25:1-5.
16. Ling P, Gately MK, Gubler U, et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995;154:116-27.
17. Zhang M, Gately MK, Wang E, et al. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-9.
18. Mattner F, Fisher S, Guckes S, et al. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 1993;23:2202-8.
19. Monteleone G, Biancone L, Marasco R, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112: 1169-78.
20. Bradley EL. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11-13, 1992. Arch Surg 1993; 128:586-90.
21. Kato K, Shimozato O, Hoshi K, et al. Local production of the p40 subunit of interleukin 12 suppresses T-helper mediated immune responses and prevents allogenic myoblast rejection. Proc Natl Acad Sci USA 1996;93:9085-9.
22. Garcia-Sabrido JL, Valdecantos E, Bastida E, Delgado JM. The anergic state as a predictor of pancreatic sepsis. Zentralbl Chir 1989;114:114-20.
23. Schulz HU, Schmidt D, Kunz D, Meyer F, Lippert H. Altered immune function in acute pancreatitis: pathogenetic role and prognostic indicator? Digestion 1993;54:307-8.
24. Pezzilli R, Billi P, Beltrandi E, et al. Circulating lymphocyte subsets in human acute pancreatitis. Pancreas 1995;11:95-100.
25. Pezzilli R, Billi P, Beltrandi E, Casadei Maldini M, Mancini R. Impaired lymphocyte proliferation in human acute pancreatitis. Digestion 1997;58:431-6.
26. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178:1041-8.
27. Leng SX, Elias JA. Interleukin-11 inhibits macrophage interleukin-12 production. J Immunol 1997;159:2161-8.
28. Pezzilli R, Billi P, Miniero R, Barakat B. Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997;42:1469-72.